Advertisement

Epigenetic Controls

Germ cells in mammals give rise to sperm and eggs. During their development, germ cells undergo extensive epigenetic reprogramming, including global DNA demethylation, which is vital for the totipotency of the developing embryo. Hackett et al. (p. 448) show that the enzymes Tet1 and Tet2 are involved in the demethylation of individual genes and in imprinted gametic differentially methylated regions. The enzymes were also responsible for the global conversion of CpG methylation to 5-hydroxymethylcytosine, which then progressively declines. The findings suggest that demethylation can occur by replication-coupled dilution, although active mechanisms cannot be excluded. A small number of loci escape demethylation, providing a possible mechanistic basis for transgenerational inheritance.

Abstract

Mouse primordial germ cells (PGCs) undergo sequential epigenetic changes and genome-wide DNA demethylation to reset the epigenome for totipotency. Here, we demonstrate that erasure of CpG methylation (5mC) in PGCs occurs via conversion to 5-hydroxymethylcytosine (5hmC), driven by high levels of TET1 and TET2. Global conversion to 5hmC initiates asynchronously among PGCs at embryonic day (E) 9.5 to E10.5 and accounts for the unique process of imprint erasure. Mechanistically, 5hmC enrichment is followed by its protracted decline thereafter at a rate consistent with replication-coupled dilution. The conversion to 5hmC is an important component of parallel redundant systems that drive comprehensive reprogramming in PGCs. Nonetheless, we identify rare regulatory elements that escape systematic DNA demethylation in PGCs, providing a potential mechanistic basis for transgenerational epigenetic inheritance.
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Supplementary Material

Summary

Materials and Methods
Figs. S1 to S24
References (25, 26)

Resources

File (hackett.sm.pdf)
File (pap.pdf)
File (papv2.pdf)

References and Notes

1
Surani M. A., Hayashi K., Hajkova P., Genetic and epigenetic regulators of pluripotency. Cell 128, 747 (2007).
2
Hajkova P., et al., Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452, 877 (2008).
3
Hackett J. A., Zylicz J. J., Surani M. A., Parallel mechanisms of epigenetic reprogramming in the germline. Trends Genet. 28, 164 (2012).
4
Tahiliani M., et al., Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930 (2009).
5
Ito S., et al., Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129 (2010).
6
Ficz G., et al., Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398 (2011).
7
Ito S., et al., Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300 (2011); 10.1126/science.1210597.
8
Maatouk D. M., et al., DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 133, 3411 (2006).
9
Hackett J. A., et al., Promoter DNA methylation couples genome-defence mechanisms to epigenetic reprogramming in the mouse germline. Development 139, 3623 (2012).
10
Hayashi K., Ohta H., Kurimoto K., Aramaki S., Saitou M., Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 146, 519 (2011).
11
Hajkova P., et al., Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 117, 15 (2002).
12
Inoue A., Zhang Y., Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334, 194 (2011); 10.1126/science.1212483.
13
Tam P. P., Snow M. H., Proliferation and migration of primordial germ cells during compensatory growth in mouse embryos. J. Embryol. Exp. Morphol. 64, 133 (1981).
14
Popp C., et al., Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463, 1101 (2010).
15
Qin C., et al., Intracisternal A particle genes: Distribution in the mouse genome, active subtypes, and potential roles as species-specific mediators of susceptibility to cancer. Mol. Carcinog. 49, 54 (2010).
16
Smallwood S. A., et al., Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat. Genet. 43, 811 (2011).
17
Borgel J., et al., Targets and dynamics of promoter DNA methylation during early mouse development. Nat. Genet. 42, 1093 (2010).
18
Kurimoto K., et al., Complex genome-wide transcription dynamics orchestrated by Blimp1 for the specification of the germ cell lineage in mice. Genes Dev. 22, 1617 (2008).
19
Gu T. P., et al., The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606 (2011).
20
Wossidlo M., et al., 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2, 241 (2011).
21
Iqbal K., Jin S. G., Pfeifer G. P., Szabó P. E., Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. U.S.A. 108, 3642 (2011).
22
Hajkova P., et al., Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 329, 78 (2010).
23
Cortellino S., et al., Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146, 67 (2011).
24
Dawlaty M. M., et al., Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9, 166 (2011).
25
Guibert S., Forné T., Weber M., Global profiling of DNA methylation erasure in mouse primordial germ cells. Genome Res. 22, 633 (2012).
26
Lao K. Q., et al., mRNA-sequencing whole transcriptome analysis of a single cell on the SOLiD system. J. Biomol. Tech. 20, 266 (2009).

Information & Authors

Information

Published In

Science
Volume 339Issue 611825 January 2013
Pages: 448 - 452

History

Received: 24 August 2012
Accepted: 16 November 2012
6 December 2012

Permissions

Request permissions for this article.

Authors

Affiliations

Jamie A. Hackett
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Roopsha Sengupta*
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Jan J. Zylicz*
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Kazuhiro Murakami*
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Caroline Lee
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Thomas A. Down
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
M. Azim Surani [email protected]
Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, UK.
Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK.
Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.

Notes

*
These authors contributed equally to this work.
†To whom correspondence should be addressed. E-mail: [email protected]

Metrics & Citations

Metrics

Citations

View Options

Media

Figures

Other

Tables

Share

Information & Authors
Published In
issue cover image
Science
Volume 339|Issue 6118
25 January 2013
Article Versions
You are viewing the most recent version of this article.
Submission history
Received:24 August 2012
Accepted:16 November 2012
Published in print:25 January 2013
Metrics & Citations
Article usage
Altmetrics
Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. The chromosomal protein SMCHD1 regulates DNA methylation and the 2c-like state of embryonic stem cells by antagonizing TET proteins, Science Advances, 7, 4, (2021)./doi/10.1126/sciadv.abb9149
    Abstract
  2. DNA methylation methods: Global DNA methylation and methylomic analyses, Methods, 187, (28-43), (2021).https://doi.org/10.1016/j.ymeth.2020.10.002
    Crossref
  3. Obesity epigenetics and exercise, Epigenetics of Exercise and Sports, (85-102), (2021).https://doi.org/10.1016/B978-0-12-820682-9.00015-3
    Crossref
  4. Ten-eleven translocation protein 1 modulates medulloblastoma progression, Genome Biology, 22, 1, (2021).https://doi.org/10.1186/s13059-021-02352-9
    Crossref
  5. Genome-wide DNA methylation dynamics during epigenetic reprogramming in the porcine germline, Clinical Epigenetics, 13, 1, (2021).https://doi.org/10.1186/s13148-021-01003-x
    Crossref
  6. Defective folate metabolism causes germline epigenetic instability and distinguishes Hira as a phenotype inheritance biomarker, Nature Communications, 12, 1, (2021).https://doi.org/10.1038/s41467-021-24036-5
    Crossref
  7. Evidence for divergence of DNA methylation maintenance and a conserved inhibitory mechanism from DNA demethylation in chickens and mammals, Genes & Genomics, 43, 3, (269-280), (2021).https://doi.org/10.1007/s13258-021-01046-7
    Crossref
  8. Exploring the evidence for epigenetic regulation of environmental influences on child health across generations, Communications Biology, 4, 1, (2021).https://doi.org/10.1038/s42003-021-02316-6
    Crossref
  9. Male obesity impacts DNA methylation reprogramming in sperm, Clinical Epigenetics, 13, 1, (2021).https://doi.org/10.1186/s13148-020-00997-0
    Crossref
  10. Epigenetics, Systemic Lupus Erythematosus, (277-292), (2021).https://doi.org/10.1016/B978-0-12-814551-7.00032-5
    Crossref
  11. See more
Loading...
Share
Share article link

Share on social media
Get Access
Log in to view the full text

AAAS Log in

AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions, as well as limited access for those who register for access.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View Options
Tables
References

(0)eLetters

No eLetters have been published for this article yet.

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.